Despite achievement of guideline targets for low-density lipoprotein cholesterol, patients with type 2 diabetes (T2D) continue to experience substantial residual vascular risk. Remnant cholesterol (RC)—the cholesterol content of triglyceride-rich lipoproteins—has been proposed as an atherogenic contributor to that residual risk. However, longitudinal evidence linking RC to microvascular outcomes, specifically diabetic retinopathy (DR), has been limited. This prospective cohort study evaluated whether repeated RC measurements predict incident DR in people with T2D who were free of DR at baseline.
The analysis used a community-based prospective cohort established between 2017 and 2019. The analytic sample comprised 1,580 Chinese adults with diagnosed T2D and no retinopathy at baseline. Participants underwent annual follow-up visits; follow-up continued until 2023 with up to five follow-up assessments reported in the abstract. The study setting and recruitment are reported as community-based; further recruitment or exclusion criteria beyond absence of DR at baseline are not detailed in the abstract.
Remnant cholesterol (RC) was the exposure of interest. The abstract reports both continuous analysis using natural log-transformed RC and a dichotomous threshold (RC ≥0.8 mmol/L). The outcome was incident diabetic retinopathy identified during annual visits; the abstract reports cumulative incident DR cases but does not provide the diagnostic criteria or grading scheme for DR in the publication abstract.
Associations between RC and incident DR were assessed using time-dependent Cox regression models, allowing RC to vary over time. The abstract states results as adjusted hazard ratios (aHRs) with 95% confidence intervals. Specific covariates included in multivariable adjustment are not listed in the abstract. Subgroup interactions were tested, and analyses were performed among participants who had achieved guideline-recommended targets for conventional lipid measures (triglycerides, LDL-C, HDL-C).
Across the follow-up period, there were 304 incident cases of DR among the 1,580 participants. In time-dependent models, each one-unit increase in natural log-transformed RC was associated with a 26% higher risk of new-onset DR (aHR 1.26, 95% CI 1.08–1.47).
When analyzed categorically, elevated RC (defined in the abstract as ≥0.8 mmol/L) was associated with a 50% increased risk of incident DR (aHR 1.50, 95% CI 1.11–2.03).
The association between elevated RC and incident DR persisted among participants who met guideline-recommended targets for triglycerides, LDL-C, and HDL-C—indicating that RC contributed to residual DR risk even when conventional lipid parameters were at target. The association was reported as more prominent in women and in patients with longer duration of T2D; the p value for interaction was reported as <0.05. The abstract does not provide detailed subgroup-specific effect estimates or the number of participants in each subgroup.
In this prospective community-based cohort of adults with T2D and no baseline retinopathy, higher longitudinal RC was independently associated with greater risk of developing DR over annual follow-up to 2023. The findings suggest that remnant cholesterol is an identifiable contributor to residual microvascular risk that is not fully captured by standard lipid measures such as LDL-C, triglycerides, or HDL-C.
Because the elevated risk remained among participants who achieved conventional lipid targets, the authors propose that RC could be considered for incorporation into routine metabolic monitoring to enhance DR risk stratification—particularly among female patients and those with long-standing diabetes, groups in which associations were stronger.
Key details are not reported in the abstract: the full list of covariates used in adjusted models, the precise methods and thresholds used to define and grade diabetic retinopathy, absolute event rates or incidence rates per person-year, and the handling of missing data. The cohort is Chinese and community-based; generalisability to other populations is not addressed in the abstract. Additional methodological details would be required from the full text to fully assess potential confounding and measurement approaches.
Elevated remnant cholesterol was associated with higher risk of incident diabetic retinopathy in this prospective cohort of adults with T2D, independent of conventional lipid targets. The study highlights RC as a potential marker of residual microvascular risk and supports consideration of RC measurement for improved DR risk stratification. Further detail on covariate adjustment, DR ascertainment, and external validation are needed to inform clinical implementation.